Kappa myeloma antigen chimeric antigen receptors and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11305011
APP PUB NO 20180228892A1
SERIAL NO

15568271

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compositions and methods for treating KMA-expressing malignancies including chimeric antigen receptors (CARs) and T cells containing CARs (CAR T-cells). The invention also provides methods and compositions comprising CAR T-cells co-expressing other anti-tumoral agents including cytokines and antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HAEMALOGIX PTY LTD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dunn, Rosanne Eveleigh, AU 4 0
Gottlieb, David Westmead, AU 11 85
Logan, Grant Westmead, AU 3 8
Micklethwaite, Kenneth Westmead, AU 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 19, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 19, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 19, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00